Journal of Health Sciences and Medicine
Yazarlar: Selçuk KAPLAN, Pınar KIRICI
Konular:Sağlık Bilimleri ve Hizmetleri
DOI:10.32322/jhsm.793486
Anahtar Kelimeler:Contraceptive Agents,Intrauterine Devices,Long-Acting Reversible Contraception,Pelvic inflammatory disease
Özet: Aim: The purpose of our study in the light of this information; to investigate the relationship between the contraceptive methods used in the patient population treated for pelvic inflammatory disease (PID) in a tertiary center with clinical and laboratory features and clinical outcome of PID. Material and Method: This is a cross-sectional study using the anamnesis, examination findings, microbiological and pathological evaluation results of vaginal and cytological samples recorded in the hospital database of 974 patients treated with a diagnosis of PID in a tertiary center between 2017 and 2019. Results: Copper-Intrauterine Device (Cu-IUD) was the most commonly used contraceptive method in women with a history of PID. When the cervicovaginal culture results are evaluated; E.coli positivity was more frequent in patients using CU-IUD and Levonorgesterone IUD (LNG-IUD) (<0.001). The frequency of reproduction was higher in Group B streptococcus (<0.001) and other streptococcus species (= 0.006) in those using condoms. While staphylococcus (= 0.041) and clamydia trochomatis positivity was higher in combined oral contraceptives (COC) users, C. Trochomatis growth was frequent in depot medroxyprogeterone acetate (DMPA) users (<0.001).Re-hospitalization was more common in the DMPA group compared to the other groups (p = 0.008). Conclusion: Contraceptive methods may affect the genital flora and may be a predisposing factor for the development of PID or prevent the development of PID.